As earlier stated, TRD is associated with HPA axis hyperactivation, which induces an over-secretion of cortisol, which desensitizes GRs, and results in impairment of the negative feedback loop, and subsequent treatment-resistant depression symptoms. Here, BCL2A1 is linked to depressive symptom measurement.